Publication Name	World Journal of Clinical Oncology
Manuscript ID	34286
Country	Türkiye

Received	2017-04-12 10:24
Peer-Review Started	2017-04-12 18:10
To Make the First Decision	2017-05-22 04:03
Return for Revision	2017-05-23 09:16
Revised	2017-06-13 12:06
Second Decision	2017-06-22 02:13
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-07-03 02:39
Articles in Press	2017-07-03 02:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-08-03 03:47
Publish the Manuscript Online	2017-08-08 01:51

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Platinum-induced neurotoxicity: A review of possible mechanisms
Manuscript Source	Invited Manuscript
All Author List	Ozkan Kanat, Hulya Ertas and Burcu Caner
Funding Agency and Grant Number
Corresponding Author	Ozkan Kanat, MD, PhD, Professor, Department of Medical Oncology, Uludag University Faculty of Medicine, Gorukle, 16059 Bursa, Turkey. ozkanat@uludag.edu.tr
Key Words	Cisplatin; Dorsal root ganglion; Mechanism; Oxaliplatin; Neurotoxicity; Neuropathic pain; Sodium channel
Core Tip	Platinum drug-based chemotherapies may lead to intolerable neuropathic symptoms, preventing their administration at the optimal effective doses and duration. A better understanding of potential mechanisms underlying these symptoms can help clinicians better manage patients experiencing acute and/or cumulative neurotoxicity during treatment with platinum-containing chemotherapy.
Publish Date	2017-08-08 01:51
Citation	Kanat O, Ertas H, Caner B. Platinum-induced neurotoxicity: A review of possible mechanisms. World J Clin Oncol 2017; 8(4): 329-335
URL	http://www.wjgnet.com/2218-4333/full/v8/i4/329.htm
DOI	http://dx.doi.org/10.5306/wjco.v8.i4.329

Full Article (PDF)	WJCO-8-329.pdf
Full Article (Word)	WJCO-8-329.doc
Manuscript File	34286-Review.docx
Answering Reviewers	34286-Answering reviewers.pdf
Audio Core Tip	34286-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	34286-Conflict-of-interest statement.pdf
Copyright License Agreement	34286-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	34286-Language certificate.pdf
Supplementary Material	34286_figure 1.docx
Peer-review Report	34286-Peer-review(s).pdf
Scientific Misconduct Check	34286-Scientific misconduct check.pdf
Scientific Editor Work List	34286-Scientific editor work list.pdf